Tolerance induction in response to liver inflammation

Digestive Diseases

Volumn 28, Issue 1, 2010, Pages 86-92

  Erhardt, Annette ^a   Tiegs, Gisa ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Concanavalin A; Immunological tolerance; Murine model

Indexed keywords

AZATHIOPRINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; PREDNISONE; RANTES; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANXIETY; AUTOIMMUNE HEPATITIS; BLOOD PRESSURE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE MODEL; EXPERIMENTAL MODEL; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; KUPFFER CELL; LIVER INJURY; LIVER LEVEL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; NATURAL KILLER T CELL; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIDE EFFECT; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; WEIGHT GAIN;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CONCANAVALIN A; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; HEPATITIS, AUTOIMMUNE; IMMUNE TOLERANCE; LIVER; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, CHEMOKINE;

EID: 77952559636     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000282069     Document Type: Review

References (61)

1. Bowen DG, McCaughan GW, Bertolino P: Intrahepatic immunity: a tale of two sites? Trends Immunol 2005;26:512-517.
2. Crispe IN: The liver as a lymphoid organ. Annu Rev Immunol 2009;27:147-163.
3. Bishop GA, McCaughan GW: Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy. Liver Transpl 2001;7:161-172.
4. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE: Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994;19:916-924.
5. Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, Bertolino P: The liver: a special case in transplantation tolerance. Semin Liver Dis 2007;27:194-213.
6. Weiner HL: Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 2001;3:947-954.
7. Knolle PA, Gerken G: Local control of the immune response in the liver. Immunol Rev 2000;174:21-34.
8. Racanelli V, Rehermann B: The liver as an immunological organ. Hepatology 2006;43:S54-S62.
9. Klugewitz K, Adams DH, Emoto M, Eulen-burg K, Hamann A: The composition ofintrahepatic lymphocytes: shaped by selective recruitment? Trends Immunol 2004;25:590-594.
10. Goddard S, Youster J, Morgan E, Adams DH: Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 2004;164:511-519.
11. Iredale JP: Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 2001;21:427-436.
12. Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, Momburg F, Arnold B, Knolle PA: Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000;6:1348-1354.
13. von Oppen N, Schurich A, Hegenbarth S, Stabenow D, Tolba R, Weiskirchen R, Geerts A, Kolanus W, Knolle P, Diehl L: Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization. Hepatology 2009;49:1664-1672.
14. Tiegs G, Hentschel J, Wendel A: A T-cell dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
15. Cao Q, Batey R, Pang G, Russell A, Clancy R: IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administered concanavalin A. Immunol Cell Biol 1998;76:542-549.
16. Tiegs G: T cells, NKT cells and NK cells in an experimental model of autoimmune hepatitis;in Gershwin ME, Vierling JM, Manns MP (eds): Textbook on Liver Immunology. Philadelphia, Hanley & Belfus, 2003, pp 171-183.
17. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K: Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000;97:5498-5503.
18. Küsters S, Gantner F, Künstle G, Tiegs G: Interferon-7 plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996;111:462-471.
19. Gantner F, Leist M, Lohse AW, Germann P, Tiegs G: Concanavalin A-induced T cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995;21:190-198.
20. Schümann J, Wolf D, Pahl A, Brune K, Papa-dopoulos T, van Rooijen N, Tiegs G: Importance of Kupffer cells for T cell-dependent liver injury in mice. Am J Pathol 2000;157:1671-1683.
21. Nicoletti F, Di Marco R, Zaccone P, Salvaggio A, Magro G, Bendtzen K, Meroni P: Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-7-dependent mechanism. Hepatology 2000;32:728-733.
22. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, Grunfeld C, Fantuzzi G: Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci USA 2000;97:2367-2372.
23. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, Nakayama T, Taniguchi M: Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000;191:105-114.
24. Di Marco R, Xiang M, Zaccone P, Leonardi C, Franco S, Meroni P, Nicoletti, F: Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency. Autoimmunity 1999;31:75-83.
25. Louis H, Moine O, Peny MO, Quertinmont E, Fokan D, Goldman M, Deviere J: Production and role ofinterleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 1997;25:1382-1389.
26. Mizuhara H, Kuno M, Seki N, Yu WG, Yamaoka M, Yamashita M, Ogawa T, Kaneda K, Fujii T, Senoh H, et al: Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Hepatology 1998;27:513-519.
27. De Silva S, Neuberger J: HLA and autoimmune hepatitis. Liver Int 2006;26:509-511.
28. McFarlane IG: Pathogenesis of autoimmune hepatitis. Biomed Pharmacother 1999;53:255-263.
29. Takamoto S, Nakamura K, Yoneda M, Makino I: Gender-related differences in concanavalin A-induced liver injury and cytokine production in mice. Hepatol Res 2003;27:221-229.
30. Lohse AW, Kögel M, Meyer zum Büschenfelde KH: Evidence for spontaneous immunosuppression in autoimmune hepatitis. Hepatology 1995;22:381-388.
31. Erhardt A, Biburger M, Papadopoulos T, Tiegs G: IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 2007;45:475-485.
32. Obermayer-Straub P, Strassburg CP, Manns MP: Autoimmune hepatitis. J Hepatol 2000;32:181-197.
33. Manns MP, Strassburg CP: Autoimmune hepatitis: clinical challenges. Gastroenterology 2001;120:1502-1517.
34. Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D, Ma Y: Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006;176:4484-4491.
35. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D: Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004;41:31-37.
36. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ: IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-3796.
37. Maloy KJ, Powrie F: Regulatory T cells in the control ofimmune pathology. Nat Immunol 2001;2:816-822.
38. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F: An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
39. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK: Inter-leukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006;212:28-50.
40. Mays LE, Chen YH: Maintaining immunological tolerance with Foxp3. Cell Res 2007;17:904-918.
41. Brusko TM, Putnam AL, Bluestone JA: Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 2007;223:371-390.
42. Ochs HD, Gambineri E, Torgerson TR: IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 2007;38:112-121.
43. Crispe IN, Giannandrea M, Klein I, John B, Sampson B, Wuensch S: Cellular and molecular mechanisms of liver tolerance. Immunol Rev 2006;231:101-118.
44. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-686.
45. You Q, Cheng L, Kedl RM, Ju C: Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 2008;48:978-990.
46. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T: Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 2007;204:57-63.
47. Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A: Chemokines and chemokine receptors: an overview. Front Biosci 2009;14:540-551.
48. Bromley SK, Mempel TR, Luster AD: Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol 2008;9:970-980.
49. Schrage A, Wechsung K, Neumann K, Schumann M, Schulzke JD, Engelhardt B, Zeitz M, Hamann A, Klugewitz K: Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemok ines. Hepatology 2008;48:1262-1272.
50. Ren X, Kennedy A, Colletti LM: CXC chemokine expression after stimulation with interferon-gamma in primary rat hepatocy tes in cu lture. Shock 2002;17:513-520.
51. Ajuebor MN, Aspinall AI, Zhou F, Le T, Yang Y, Urbanski SJ, Sidobre S, Kronenberg M, Hogaboam CM, Swain MG: Lack of chemok ine receptor CCR 5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J Immunol 2005;174:8027-8037.
52. Ajuebor MN, Wondimu Z, Hogaboam CM, Le T, Proudfoot AE, Swain MG: CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. Am J Pathol 2007;170:1975-1988.
53. Moreno C, Gustot T, Nicaise C, Quertinmont E, Nagy N, Parmentier M, Le Moine O, Deviere J, Louis H: CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology 2005;42:854-862.
54. Ajuebor MN, Carey JA, Swain MG: CCR5 in T cell-mediated liver diseases: what's going on? J Immunol 2006;177:2039-2045.
55. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, Taylor PA, McKinnon KP, Su L, Blazar BR, Serody JS: Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 2005;106:3300-3307.
56. Liu L, Callahan MK, Huang D, Ransohoff RM: Chemokine receptor CXCR3: an unexpected enigma. Curr Top Dev Biol 2005;68:149-181.
57. Uppaluri R, Sheehan KC, Wang L, Bui JD, Brotman JJ, Lu B, Gerard C, Hancock WW, Schreiber RD: Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation 2008;86:137-147.
58. Chen D, Bromberg JS: T regulatory cells and migration. Am J Transplant 2006;6:1518-20212223.
59. Eksteen B, Miles A, Curbishley SM, Tselepis C, Grant AJ, Walker LS, Adams DH: Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J Immunol 2006;177:593-603.
60. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ: The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009;10:595-602.
61. Horuk R: Chemokine receptor antagonists: overcoming developmental hurdles. Nat Rev Drug Discov 2009;8:23-33.